Method of assembling and filling a drug delivery device

1. A method of assembling an injector, the method comprising:

providing a container having a wall defining an interior surface and a seal assembly, the wall and seal assembly defining a reservoir;

providing a fluid delivery system physically separate from the container, the fluid delivery system comprising a container needle having a point;

sterilizing the container including the reservoir and fluid delivery system while the container and the fluid delivery system are separate from each other;

filling the reservoir of the container with a volume of a drug product under sterile conditions;

after filling the reservoir of the container, attaching the fluid delivery system to the filled container under clean room conditions such that the point of the container needle is disposed adjacent to the seal assembly to define a storage state; and

attaching the container needle to an actuator, the actuator adapted to move the container needle from the storage state to a delivery state wherein the container needle is disposed through the seal assembly, into the reservoir, and in fluid communication with the drug product for delivery to a patient,

wherein the seal assembly includes a first wall and a second wall, the reservoir is defined at least by the interior surface of the wall of the container and a first surface of the first wall of the seal assembly, an enclosed clean space is defined at least by a second surface of the first wall of the seal assembly and the second wall of the seal assembly, and the point of the container needle is disposed through the second wall of the seal assembly into the enclosed clean space prior to the delivery state and disposed through the first wall of the seal assembly into the reservoir in the delivery state.

2. The method of claim 1 , wherein filling the reservoir with a volume of a drug product comprises filling the reservoir with a volume of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9)—specific antibody or a granulocyte colony-stimulating factor (G-CSF).

3. The method of claim 1 , further comprising attaching a stopper to the container after filling the reservoir, thereby sealing the filled reservoir.

4. The method of claim 3 , wherein attaching the stopper to the container includes attaching the stopper to the container in a space operated as an aseptic Class 100 clean room.

5. The method of claim 1 , wherein attaching the fluid delivery system to the filled container comprises attaching the container needle such that the container needle does not penetrate a wall of the seal assembly.

6. The method of claim 1 , wherein sterilizing the container comprises a radiation sterilization treatment and/or a gaseous sterilization treatment.

7. The method of claim 1 , wherein filling the reservoir of the container includes filling the reservoir in a space operated as an aseptic Class 100 clean room.

8. The method of claim 1 , prior to attaching the fluid delivery system to the container, inspecting the filled container in a space operated as an aseptic Class 10,000 clean room.

9. The method of claim 1 , prior to attaching the fluid delivery system to the container, moving the filled container to an assembly space operated as an aseptic Class 10,000 clean room.

10. The method of claim 1 , further comprising swabbing a surface of the seal assembly prior to attaching the fluid delivery system.

11. The method of claim 1 , wherein the reservoir of the container is filled in a first assembly space, and the fluid delivery system is attached to the filled container in a second assembly space, wherein the second assembly space has a lower level of cleanliness than the first assembly space.

12. The method of claim 1 , providing an injection needle physically separate from the container needle and configured to be connected in fluid communication with the container needle during use of the injector.

13. The method of claim 12 , wherein the fluid delivery system comprises at least one flexible tubing configured to provide fluid communication between the container needle and the injection needle.

14. The method of claim 1 , wherein the container needle comprises a first end and a second end, the first end including the point, the second end being unsheathed and/or coupled with a fluid conduit in the storage state.

15. A method of assembling an injector, the method comprising:

providing a container having a wall defining an interior surface and a seal assembly, the wall and seal assembly defining a reservoir;

providing a fluid delivery system physically separate from the container, the fluid delivery system comprising a container needle having a point;

sterilizing the container including the reservoir and fluid delivery system while the container and the fluid delivery system are separate from each other;

filling the reservoir of the container with a volume of a drug product under sterile conditions;

attaching the fluid delivery system to the filled container under clean room conditions such that the point of the container needle is disposed within the seal assembly to define a storage state; and

attaching the container needle to an actuator, the actuator adapted to move the container needle from the storage state to a delivery state wherein the container needle is disposed through the seal assembly, into the reservoir, and in fluid communication with the drug product for delivery to a patient,

wherein the seal assembly includes a first wall and a second wall, the reservoir is defined at least by the interior surface of the wall of the container and a first surface of the first wall of the seal assembly, an enclosed clean space is defined at least by a second surface of the first wall of the seal assembly and the second wall of the seal assembly, and the point of the container needle is disposed through the second wall of the seal assembly into the enclosed clean space in the storage state and disposed through the first wall of the seal assembly into the reservoir in the delivery state.

16. The method of claim 15 , wherein filling the reservoir with a volume of a drug product comprises filling the reservoir with a volume of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9)—specific antibody or a granulocyte colony-stimulating factor (G-CSF).

17. The method of claim 15 , further comprising attaching a stopper to the container after filling the reservoir, thereby sealing the filled reservoir.

18. The method of claim 17 , wherein attaching the stopper to the container includes attaching the stopper to the container in a space operated as an aseptic Class 100 clean room.

19. The method of claim 15 , wherein sterilizing the container comprises a radiation sterilization treatment and/or a gaseous sterilization treatment.

20. The method of claim 15 , wherein filling the reservoir of the container includes filling the reservoir in a space operated as an aseptic Class 100 clean room.

21. The method of claim 15 , prior to attaching the fluid delivery system to the container, moving the filled container to an assembly space operated as an aseptic Class 10,000 clean room.

22. The method of claim 15 , wherein the reservoir of the container is filled in a first assembly space, and the fluid delivery system is attached to the filled container in a second assembly space, wherein the second assembly space has a lower level of cleanliness than the first assembly space.